What Documentation European Buyers Need for Reusable Forceps

European buyers purchasing reusable forceps need more than a quotation, product photograph and general material statement. They may need evidence covering the product’s intended purpose, regulatory status, material traceability, functional performance, reprocessing instructions, labelling and post-market responsibilities.

The exact documentation depends on how the forceps will be marketed.

Reusable forceps intended for surgery or another medical purpose may fall under the EU Medical Device Regulation, Regulation (EU) 2017/745. Laboratory, beauty, industrial or household forceps without an intended medical purpose may instead fall under the General Product Safety Regulation or other applicable legislation.

This distinction must be resolved before the manufacturer prepares packaging, applies a CE mark or makes claims such as “surgical,” “medical,” “sterile” or “autoclavable.”

This article provides general regulatory information and is not a substitute for advice from an EU regulatory professional, notified body or competent authority.

First Determine the Intended Purpose

The intended purpose controls the product’s regulatory route. It is established through the manufacturer’s:

• Product label
• Instructions for use
• Website descriptions
• Catalogue
• Advertising
• Technical specifications
• Sales communications
• Clinical or professional claims

A forceps described as a “general-purpose precision forceps” may have a different regulatory status from the same physical instrument marketed as “reusable surgical tissue forceps.”

Before accepting an order, the manufacturer and buyer should agree on:

1. Who will use the forceps
2. Where it will be used
3. What tissue, material or component it will contact
4. Whether it will enter the human body
5. How long contact will last
6. Whether it is reusable
7. Whether it is supplied sterile or non-sterile
8. Whether it connects to an active device
9. Who will appear as the legal manufacturer
10. In which European countries it will be sold

The product cannot be classified correctly until these questions are answered.

Medical vs Non-Medical Reusable Forceps

A buyer should never assume that every reusable forceps is a Class I medical device.

Are Reusable Surgical Forceps Class I?

Many conventional reusable surgical forceps used transiently during surgery may qualify as Class I reusable surgical instruments, commonly written as Class Ir.

The EU MDR defines a reusable surgical instrument as an instrument intended for surgical use—such as cutting, drilling, clamping, retracting, clipping or similar procedures—that is not connected to an active device and is intended to be reused after appropriate processing.

Under Rule 6 of MDR Annex VIII, reusable surgical instruments are generally Class I. The European Commission’s current classification guidance lists forceps among the examples covered by this rule. However, intended use involving the heart, central circulatory system, central nervous system or other special conditions can produce a higher classification. See MDCG 2021-24 Rev.1.

Classification must be documented for each product family. Writing “Class I” on a quotation without a formal classification rationale is not sufficient.

Does Class Ir Require a Notified Body?

Yes. Class Ir devices require notified-body involvement.

For reusable surgical instruments, the notified body’s assessment is generally limited to the aspects related to reuse, including:

• Cleaning
• Disinfection
• Sterilization
• Maintenance
• Functional testing
• Associated instructions for use

If the device is also supplied sterile, the notified body’s scope must cover the applicable sterile-device requirements.

The European Commission’s Class I factsheet confirms that notified-body involvement is required for devices supplied sterile, devices with a measuring function and reusable surgical instruments. Review the official Class I guidance.

Core Documentation European Buyers Should Request

A complete documentation package for reusable medical forceps normally includes the following categories.

1. Product Description and Intended-Purpose Statement

The product description should identify:

• Product name
• Model or catalogue number
• Forceps type
• Straight or curved profile
• Toothed or non-toothed jaws
• Serration pattern
• Ratchet or non-ratchet design
• Overall length
• Material
• Surface finish
• Intended medical purpose
• Intended user
• Intended patient population
• Anatomical contact
• Duration of use
• Reusable status
• Sterile or non-sterile supply condition
• Available variants

The wording must remain consistent across the technical file, EU Declaration of Conformity, label, IFU, catalogue and website.

2. Regulatory Classification Rationale

The classification document should explain:

• Why the product qualifies as a medical device
• Which MDR classification rule applies
• Why it qualifies—or does not qualify—as a reusable surgical instrument
• Whether it is surgically invasive
• Duration of contact
• Whether it contacts the heart, central circulatory system or central nervous system
• Whether it connects to an active device
• Final risk class
• Any sterile or measuring characteristics

A simple statement reading “Class Ir according to Rule 6” may not be enough. The rationale should connect the product’s intended purpose with the definitions and classification rules.

3. EU Declaration of Conformity

The legal manufacturer must prepare and sign an EU Declaration of Conformity after completing the applicable conformity-assessment process.

It should identify:

• Legal manufacturer
• Registered address
• Product or product family
• Basic UDI-DI
• Risk class
• Applicable regulation
• Conformity-assessment route
• Notified body, where applicable
• Certificate reference
• Applicable standards or common specifications
• Name and authority of the signatory
• Date and place of issue

The Declaration of Conformity is not the same as a notified-body certificate or ISO 13485 certificate. European buyers may need all three documents.

4. Notified-Body Certificate

For Class Ir devices, the buyer should request a copy of the valid notified-body certificate and verify:

• Notified-body name
• Four-digit identification number
• Certificate holder
• Manufacturer’s legal name and address
• Certificate number
• Device scope
• Class Ir or reusable-instrument coverage
• Issue and expiry dates
• Conditions or limitations
• Certificate status in the appropriate database

The product must fall within the certificate’s scope. A certificate for unrelated instruments or a different legal manufacturer does not cover the forceps automatically.

5. CE-Marking Evidence

The CE mark should only be applied after the applicable MDR requirements and conformity-assessment process have been completed.

For a Class Ir forceps involving a notified body, the CE mark is normally accompanied by the notified body’s four-digit identification number.

The buyer should review the actual:

• Product marking
• Primary packaging
• Secondary packaging
• Label artwork
• IFU
• Catalogue representation

The name and address of the legal manufacturer must match the Declaration of Conformity and certificate.

6. EU Authorised Representative Documentation

A manufacturer established outside the EU must appoint an authorised representative located inside the EU before placing a medical device on the European market.

The manufacturer and authorised representative need a written mandate defining the representative’s tasks. The authorised representative’s name and address must appear on the label or accompanying information as required.

The European Commission explains that non-EU manufacturers must have an EU authorised representative under MDR Article 11. Read the official economic-operator factsheet.

European buyers may request:

• Authorised-representative agreement confirmation
• Authorised-representative name and address
• SRN
• Mandate coverage
• Label placement
• Contact procedure for complaints and incidents

7. Importer and Distributor Information

The first EU company placing a device from a non-EU country on the Union market normally acts as the importer.

The importer must verify important compliance elements, including:

• CE marking
• EU Declaration of Conformity
• Manufacturer identification
• Authorised representative
• Required labelling and IFU
• UDI assignment, where applicable
• Product registration
• Storage and transport conditions

The importer’s name and address must also be indicated on the device, packaging or accompanying documentation as permitted by the MDR.

Distributors must verify appropriate compliance information and maintain systems for complaints, nonconforming devices, recalls and withdrawals. MDCG 2021-27 Rev.1 explains these importer and distributor responsibilities.

8. EUDAMED and SRN Records

As of 28 May 2026, the EUDAMED Actor Registration, UDI/Device Registration, Notified Bodies and Certificates, and Market Surveillance modules are mandatory to use.

Relevant economic operators need the appropriate registration and Single Registration Number.

A European buyer may request confirmation of:

• Manufacturer SRN
• Authorised-representative SRN
• Importer SRN
• Basic UDI-DI
• UDI-DI
• EUDAMED device registration
• Notified-body certificate registration

The European Commission provides the current requirements on its EUDAMED overview page.

9. UDI Information

Class I medical devices have required UDI carriers on their labels since 26 May 2025.

Reusable devices that require cleaning, disinfection, sterilization or refurbishment between uses must generally bear a permanent UDI carrier directly on the device. For Class I reusable devices, the direct-marking requirement applies from 26 May 2027, subject to the MDR’s limited exemptions.

A direct UDI marking must remain readable throughout the device’s intended lifetime and repeated reprocessing.

Direct marking may not be required where:

• It would interfere with safety or performance
• Direct marking is not technologically feasible

The justification for an exemption should be documented. European Commission UDI guidance explains the direct-marking requirements.

For reusable forceps, the manufacturer should plan adequate laser-marking space before finalizing the handle design.

10. Technical Documentation

MDR Annexes II and III require technical documentation and post-market-surveillance documentation for medical devices of every class.

The file normally includes:

• Device description
• Intended purpose
• Product variants
• Classification rationale
• Design drawings
• Manufacturing information
• Raw-material specifications
• Supplier controls
• General Safety and Performance Requirements checklist
• Risk-management file
• Verification and validation evidence
• Biological evaluation
• Clinical evaluation
• Reprocessing validation
• Labelling and IFU
• Post-market-surveillance plan
• Complaint and vigilance procedures

A buyer may not always receive the manufacturer’s entire confidential technical file. However, the legal manufacturer, authorised representative and relevant authorities must have appropriate access, and the importer must obtain enough evidence to perform its regulatory obligations.

11. General Safety and Performance Requirements Checklist

The GSPR checklist should map each applicable MDR Annex I requirement to:

• Applicable or not applicable
• Justification
• Standard or test method used
• Supporting report
• Technical-file reference
• Evidence of conformity

This prevents compliance from being reduced to a generic CE statement. The checklist shows how the manufacturer addressed every relevant safety and performance requirement.

12. Quality-Management-System Documentation

European buyers commonly request an ISO 13485 certificate from a recognized certification body.

They may review:

• ISO 13485 certificate
• Certificate scope
• Manufacturing-site address
• Product categories covered
• Audit status
• Certificate expiry
• Critical subcontractors
• Change-control procedure
• Nonconformance process
• Corrective and preventive action process
• Complaint handling
• Traceability procedures

ISO 13485 certification does not itself authorize CE marking. It supports the manufacturer’s quality-management system but does not replace product-specific conformity assessment.

13. Material Certificates

A reusable-forceps material file may include:

• Exact stainless-steel grade
• Chemical composition
• Heat or batch number
• Supplier mill certificate
• EN 10204 3.1 certificate when contractually requested
• Hardness data
• Corrosion-resistance data
• Surface-finish specification
• Passivation record
• Restricted-substance declaration

ISO 7153-1 specifies metallic materials commonly used for standard surgical instruments, including instruments used in general surgery and dentistry. See ISO 7153-1:2016.

The product page should identify the verified material grade instead of saying only “100% stainless steel.”

14. Manufacturing and Batch-Traceability Records

European buyers may request evidence connecting the finished instruments to the approved raw materials and production records.

Useful records include:

• Purchase-order number
• Batch or lot number
• Raw-material heat number
• Production date
• Work-order reference
• Heat-treatment record
• Grinding and alignment record
• Passivation record
• Final-inspection report
• Packaging record
• Quantity released
• Name or identification of the release inspector

For OEM orders, the quality agreement should define how long records are retained and how quickly they can be retrieved after a complaint.

15. Functional and Performance Test Reports

The tests depend on the type of forceps.

Possible evaluations include:

• Overall dimensions
• Jaw and tip alignment
• Tooth engagement
• Serration consistency
• Closing contact
• Handle symmetry
• Spring force
• Ratchet engagement
• Lock release
• Hinge movement
• Surface roughness
• Burr inspection
• Corrosion resistance
• Cleaning resistance
• Repeated-use simulation
• Reprocessing-cycle durability
• Marking legibility

ISO 7151:2024 covers general requirements and test methods for non-cutting articulated surgical instruments. The applicable test standards must be selected according to the forceps design and intended use.

16. Risk-Management File

Reusable forceps require a documented risk-management process throughout the product lifecycle.

Possible hazards include:

• Tip breakage
• Jaw misalignment
• Excessive tissue pressure
• Corrosion
• Residual contamination
• Inadequate cleaning
• Incomplete sterilization
• Sharp burrs
• Ratchet failure
• Material sensitivity
• Incorrect reuse
• Use beyond the instrument’s service life
• Loss of UDI legibility
• Packaging damage
• Use of an incorrect sterilization cycle

ISO 14971:2019 provides an internationally recognized framework for medical-device risk management. Review the ISO overview.

The risk file should connect identified hazards with design controls, testing, IFU warnings and post-market monitoring.

17. Biological-Evaluation Documentation

Forceps that contact a patient require a biological evaluation based on:

• Type of contact
• Contacting material
• Contact duration
• Manufacturing residues
• Cleaning agents
• Passivation chemicals
• Surface treatments
• Existing material data
• Chemical characterization
• Risk assessment
• Additional testing where required

The current ISO 10993-1:2025 framework places biological evaluation within the wider risk-management process.

A material certificate alone does not prove biological safety. Evaluation must consider the finished device, including manufacturing and cleaning residues.

18. Clinical-Evaluation Report

All medical devices require an appropriate clinical evaluation under the MDR.

For well-established reusable forceps, the evaluation may rely on a combination of:

• Device description
• State of the art
• Clinical literature
• Equivalent-device data where equivalence can be demonstrated
• Complaint history
• Post-market information
• Benefit-risk analysis
• Justification for whether clinical investigation is needed

The clinical evaluation must relate to the manufacturer’s exact intended purpose and claims. A generic report for “surgical instruments” may be inadequate if it does not address the specific forceps family.

19. Reprocessing Validation

Reprocessing documentation is one of the most important parts of a Class Ir forceps file.

The manufacturer must provide validated instructions that allow the user to prepare the forceps safely for reuse.

The validation should address:

• Point-of-use preparation
• Safe transport after use
• Pre-cleaning
• Manual cleaning
• Automated washer-disinfector cleaning
• Detergent type and concentration
• Water quality
• Cleaning time and temperature
• Rinsing
• Disinfection
• Drying
• Inspection
• Maintenance
• Packaging before sterilization
• Validated sterilization method
• Cycle parameters
• Storage
• Functional testing
• Reuse limitations
• End-of-life criteria

ISO 17664-1:2021 specifies the information manufacturers should provide for processing critical and semi-critical medical devices before use and reuse. See the ISO standard overview.

The IFU should not simply state “autoclavable.” It should provide a validated procedure or clearly reference the validated parameters.

20. Reuse-Life or End-of-Life Criteria

Some reusable instruments are assigned a maximum number of validated cycles. Others are used until defined inspection criteria indicate that they must be removed from service.

The manufacturer should state the applicable approach.

End-of-life indicators may include:

• Corrosion
• Pitting
• Cracks
• Bent tips
• Jaw misalignment
• Worn serrations
• Tooth damage
• Loose hinge
• Ratchet failure
• Permanent staining
• Damaged surface finish
• Unreadable product identification
• Failed functional test

If no fixed reuse-cycle limit is stated, the risk-management and validation files should justify the inspection-based approach.

21. Labelling and Instructions for Use

The label and IFU may need to include:

• Device name
• Catalogue number
• Legal manufacturer
• Authorised representative
• Importer
• UDI
• Batch or lot number
• CE mark
• Notified-body number
• Non-sterile symbol
• Reusable status
• Material information
• Intended purpose
• Contraindications
• Warnings
• Reprocessing instructions
• Inspection procedure
• Storage conditions
• Disposal information
• Date or revision of the IFU

Information must be supplied in the languages required by each Member State where the device is sold. The European Commission maintains a current MDR language-requirements table.

English-only packaging is not automatically sufficient for every European market.

22. Sterile-Product Documentation

If forceps are supplied sterile, additional documentation may include:

• Sterilization validation
• Sterilization method
• Bioburden data
• Sterility-assurance information
• Packaging validation
• Seal-strength testing
• Package-integrity testing
• Shelf-life validation
• Transport simulation
• Sterilization-lot records
• Sterile barrier specifications

The applicable notified-body scope must cover sterile supply.

Non-sterile forceps should not carry a sterile claim merely because they can later be sterilized by a healthcare facility.

23. Packaging and Transport Documentation

Even non-sterile reusable forceps need protective packaging that prevents damage and contamination during transportation.

Buyers may request:

• Packaging specification
• Tip protection
• Individual sleeves
• Box material
• Label placement
• Drop or transport test
• Humidity protection
• Packaging cleanliness
• Carton configuration
• Pallet plan
• Barcode details
• Shipping marks

Packaging should prevent fine tips, teeth and ratchets from striking other instruments.

24. Post-Market-Surveillance Documentation

Class I manufacturers must establish a post-market-surveillance system.

Relevant documentation includes:

• PMS plan
• PMS report
• Complaint procedure
• Trend-review process
• Vigilance procedure
• Field-safety corrective-action procedure
• Recall procedure
• Distributor feedback process
• Corrective and preventive actions
• Periodic review of risk and clinical evaluation

For Class I devices, the manufacturer generally prepares a PMS report under MDR Article 85 rather than the periodic safety update report required for higher classes.

Private-Label Forceps: Who Is the Legal Manufacturer?

Private labelling creates an important regulatory question.

The legal manufacturer is not necessarily the factory that physically produces the forceps. It is the company that places the device on the market under its name or trademark and assumes the manufacturer’s regulatory obligations.

Possible structures include:

Factory remains the legal manufacturer

The factory’s name appears as the manufacturer, and the European brand operates as importer or distributor under a documented agreement.

European brand becomes the legal manufacturer

The brand places the product on the market under its name and assumes responsibility for:

• MDR compliance
• Technical documentation
• Conformity assessment
• Notified-body relationship
• Declaration of Conformity
• UDI
• EUDAMED
• Labelling
• PMS
• Vigilance
• Complaints
• Regulatory changes

The factory acts as a contract manufacturer and supplies manufacturing and quality documentation.

Relabelling or repackaging arrangement

If an importer or distributor changes the label, packaging or product presentation, MDR Article 16 obligations may apply. Regulatory roles must be reviewed before artwork is approved.

European buyers and OEM factories should settle the legal-manufacturer structure in the quality agreement. A buyer should not add its brand to a CE-marked forceps and assume the original certificate automatically transfers.

What Non-Medical Forceps Need

If the forceps have no intended medical purpose and are supplied as consumer products, the EU General Product Safety Regulation may apply.

The manufacturer may need:

• Product identification
• Manufacturer details
• EU responsible economic operator
• Importer details
• Product risk analysis
• Technical documentation
• Material and chemical-safety information
• Batch traceability
• Instructions and warnings
• Complaint and recall process
• Safety-incident reporting
• Online-listing information

The GPSR has applied since 13 December 2024. It does not create a general CE-marking requirement for ordinary consumer forceps.

A CE mark should not be added to a non-medical forceps unless another EU law specifically requiring CE marking applies.

Documentation Buyers Should Check at Each Stage

Before requesting samples

• Intended purpose
• Regulatory route
• Classification
• Legal-manufacturer structure
• Material grade
• Device dimensions
• Reusable and sterile status
• Target EU countries

Before placing the purchase order

• Quality agreement
• Product specification
• Classification rationale
• Certificate scope
• Declaration of Conformity format
• Reprocessing-validation plan
• Labelling responsibilities
• UDI responsibilities
• Change-control requirements
• Batch-document requirements

Before approving production

• Approved sample
• Drawings and tolerances
• Material certificate
• Functional test plan
• Label artwork
• IFU
• Packaging specification
• Direct-marking position
• Inspection criteria

Before shipment

• Batch-release certificate
• Final-inspection report
• Material traceability
• Signed Declaration of Conformity
• Valid notified-body certificate
• Final label and IFU
• UDI confirmation
• EUDAMED registration
• Packing list
• Commercial invoice
• Country-of-origin documentation where required

Common Documentation Mistakes

Treating ISO 13485 as product approval

An ISO 13485 certificate supports the quality system but does not replace CE conformity assessment.

Using a material certificate as biological evidence

Material chemistry is only one part of biological evaluation.

Saying only “autoclavable”

European buyers need validated reprocessing instructions, not a general marketing claim.

Using an unrelated CE certificate

The certificate holder, product scope and legal manufacturer must match the device.

Applying CE marking to non-medical forceps

The GPSR does not provide a general CE-marking route.

Ignoring translation requirements

IFU and safety information may need multiple European languages.

Changing private-label artwork without reviewing regulatory roles

A new brand name can change who is treated as the legal manufacturer.

Failing to prepare for direct UDI marking

Class I reusable devices face direct-marking requirements from 26 May 2027 unless an exemption applies.

Recommended EU Buyer Documentation Pack

TWEEZER WORLD® should structure each qualifying reusable-forceps project with a controlled documentation folder containing:

1. Product specification
2. Approved drawing
3. Intended-purpose statement
4. Classification support supplied by the responsible legal manufacturer
5. Material certificate
6. Manufacturing batch record
7. Dimensional inspection report
8. Functional test report
9. Surface and corrosion inspection
10. Reprocessing-support data
11. Approved marking artwork
12. Packaging specification
13. Final quality-control report
14. Certificate of Conformity for the shipment
15. Change-control record

Regulatory documents such as the MDR technical file, clinical evaluation, EU Declaration of Conformity, EUDAMED registration and notified-body certificate remain the responsibility of the identified legal manufacturer, supported by the contract manufacturer’s production evidence.

TWEEZER WORLD® can align manufacturing, material traceability, batch inspection and OEM packaging with agreed buyer requirements. Medical-device or sterilization claims should only be published after the applicable evidence and regulatory process are complete.

Explore TWEEZER WORLD® instrument manufacturing capabilities, review an example of Adson Dressing and Tissue Forceps, or discuss an OEM and Private-Label project.

Frequently Asked Questions

Do reusable surgical forceps need CE marking in Europe?

Yes, when they qualify as medical devices under the MDR. The appropriate conformity-assessment process must be completed before applying the CE mark.

Are reusable forceps always Class Ir?

No. Classification depends on the intended purpose, invasiveness, contact duration, anatomy and whether the instrument connects to an active device.

Does Class Ir require a notified body?

Yes. Notified-body involvement is required for aspects related to reuse, including cleaning, disinfection, sterilization, maintenance, functional testing and the related instructions.

Is ISO 13485 enough to sell forceps in Europe?

No. ISO 13485 supports the manufacturer’s QMS but does not replace product classification, technical documentation, conformity assessment, CE marking or the EU Declaration of Conformity.

What material certificate should a buyer request?

Buyers commonly request the exact stainless-steel grade, chemical composition, heat number and an EN 10204 3.1 certificate where contractually required.

Must the IFU include sterilization parameters?

The IFU should provide validated processing instructions applicable to the device, including cleaning, disinfection and sterilization information where required.

Do reusable forceps need a UDI marked directly on the instrument?

Reusable devices generally require direct UDI marking. For Class I reusable devices, the requirement applies from 26 May 2027, subject to documented exemptions.

Can a European brand put its logo on an existing CE-marked forceps?

Possibly, but doing so may affect the company’s regulatory role and obligations. The legal-manufacturer arrangement and MDR Article 16 implications should be reviewed before relabelling.

Do non-medical forceps need CE marking?

Not simply because they are sold in Europe. Consumer forceps may fall under the GPSR, which does not itself require CE marking.

Can a Pakistani manufacturer be the legal manufacturer for the EU?

Yes, provided it meets the applicable MDR obligations, appoints an EU authorised representative and completes the required conformity assessment, registration and documentation.

Conclusion

European reusable-forceps buyers need a documentation system, not a loose collection of certificates.

For medical forceps, the essential package begins with a defined intended purpose, documented classification, technical file, risk management, biological and clinical evaluation, validated reprocessing instructions, notified-body involvement where required, EU representation, UDI, EUDAMED registration and post-market controls.

For non-medical forceps, buyers should establish the applicable general-product rules and avoid inappropriate medical or CE claims.

The strongest OEM partnership is created when the buyer and factory agree on regulatory roles, specifications, testing, traceability and documentation before sample approval—not after the goods are ready to ship.